APHP Awards €39M Laboratory Reagents Framework Agreements

AGEPS - APHP, a body governed by public law operating in health, has awarded framework agreements for the supply of in vitro diagnostic medical devices: reagents, kits, calibration and control plasmas for haemostasis, and associated services (la fourniture de Dispositifs Médicaux de Diagnostic In Vitro : réactifs, trousses, plasmas de calibration et de contrôle d'hémostase, et des prestations associées) for all establishments of the Assistance Publique - Hôpitaux de Paris. The total maximum value of the framework agreements is €38,995,033.00, covering laboratory reagents, with an estimated duration of 48 months. The contracts were awarded following an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Introduction

AGEPS - APHP, a body governed by public law operating in health, has conducted an open procedure for the supply of in vitro diagnostic medical devices: reagents, kits, calibration and control plasmas for haemostasis, and associated services for all establishments of the Assistance Publique - Hôpitaux de Paris. The procurement was divided into multiple lots, grouped into five result lots. The evaluation criteria are quality of the service (60%) with four sub-criteria (technical quality 35%, adaptation to hospital use 10%, tenderer's services 10%, sustainable development actions 5%) and price (40%). Three tenders were received electronically for each lot.

The procurement is not financed with EU funds but is covered by the Government Procurement Agreement (GPA). Framework agreements were concluded without reopening of competition. Five winners were appointed: Cryopep, Diagnostica Stago, Siemens Healthcare, Sysmex France, and Werfen. No subcontracting was declared. The contracts were concluded on 25/09/2026. The total maximum value of the framework agreements in this notice is €38,995,033.00.

Why This Contract Matters

This contract ensures the supply of in vitro diagnostic medical devices, reagents, kits, calibration and control plasmas for haemostasis, and associated services for all establishments of the Assistance Publique - Hôpitaux de Paris, supporting hospital diagnostic operations.

This contract matters because it:

• Supports Hospital Diagnostics: Supplies reagents, kits, calibration and control plasmas for haemostasis testing
• Significant Value: €38,995,033.00 total maximum value
• Medium-Term Commitment: 48-month duration
• Comprehensive Scope: In vitro diagnostic medical devices and associated services across multiple lots
• Balanced Evaluation: 60% quality, 40% price
• Competition: 3 tenders received electronically per lot
• No Subcontracting: No subcontracting declared by winners

Contract Timeline

• Contract concluded: 25/09/2026
• Estimated duration: 48 months
• Notice published: 02 October 2026 (OJ S 191/2026)
• Notice dispatch date: 01 October 2026

Contract Overview

AGEPS - APHP conducted an open procedure under the standard regime, governed by EU Directive 2014/24/EU.

Key features include:

• Five result lots: LOT-0001 to LOT-0005
• Total maximum value: €38,995,033.00
• Duration: 48 months
• Framework type: Framework agreement, without reopening of competition
• Evaluation: Quality (60%) and Price (40%)
• Winners: Cryopep, Diagnostica Stago, Siemens Healthcare, Sysmex France, Werfen (all micro, small, or medium enterprises)
• Subcontracting: No
• No EU funding
• Covered by GPA: Yes

Key Contract Details

• Main classification: 33696500 Laboratory reagents
• Place of performance: Paris (FR101), France
• Procedure identifier: 530f5931-2cbb-4e22-ad68-6e0e2e0d0063
• Internal identifier: AGEPS AO 26-06L
• Type of procedure: Open
• Legal basis: Directive 2014/24/EU
• Review body: Tribunal Administratif de PARIS

Lot Structure

Lot 1 – CRYOPEP Lots 13 et 35

• Title: CRYOPEP Lots 13 et 35
• Description: CRYOPEP Lots 13 et 35
• Maximum value: €1,665,465.00
• Winner: Cryopep
• Tenders received: 3
• Contract concluded: 25/09/2026
• Duration: 48 months
• Contract identifier: 2026AGEC266065

Lot 2 – DIAGNOSTICA STAGO lot 1

• Title: DIAGNOSTICA STAGO lot 1
• Description: DIAGNOSTICA STAGO Lots 1, 7, 8, 12, 15, 16, 27, 28, 31, 32, 34, 36
• Maximum value: €19,773,422.00
• Winner: DIAGNOSTICA STAGO
• Tenders received: 3
• Contract concluded: 25/09/2026
• Duration: 48 months
• Contract identifier: 2026AGEC266067

Lot 3 – Siemens healthcare lot 3

• Title: Siemens healthcare lot 3
• Description: Siemens Healthcare Lots n° 3, 5, 6, 11, 23, 25, 29 et 33
• Maximum value: €5,435,095.00
• Winner: SIEMENS HEALTHCARE
• Tenders received: 3
• Contract concluded: 25/09/2026
• Duration: 48 months
• Contract identifier: 2026AGEC266066

Lot 4 – Symex france Lots n° 4

• Title: Symex france Lots n° 4
• Description: Symex france Lots n° 4, 14, 17, 18, 19, 20, 21, 22 et 30
• Maximum value: €7,012,420.00
• Winner: SYSMEX FRANCE
• Tenders received: 3
• Contract concluded: 25/09/2026
• Duration: 48 months
• Contract identifier: 2026AGEC266068

Lot 5 – Werfen Lots n° 2, 9, 10 et 26

• Title: Werfen Lots n° 2, 9, 10 et 26
• Description: Werfen Lots n° 2, 9, 10 et 26
• Maximum value: €5,108,631.00
• Winner: WERFEN
• Tenders received: 3
• Contract concluded: 25/09/2026
• Duration: 48 months
• Contract identifier: 2026AGEC266069

Lot Summary Table

Lot	Title	Value (€)	Winner	Tenders
1	CRYOPEP Lots 13 et 35	1,665,465.00	Cryopep	3
2	DIAGNOSTICA STAGO lot 1	19,773,422.00	DIAGNOSTICA STAGO	3
3	Siemens healthcare lot 3	5,435,095.00	SIEMENS HEALTHCARE	3
4	Symex france Lots n° 4	7,012,420.00	SYSMEX FRANCE	3
5	Werfen Lots n° 2, 9, 10 et 26	5,108,631.00	WERFEN	3
Total		38,995,033.00

Scope of Supply

The contract covers the following supplies:

• In Vitro Diagnostic Medical Devices: Supply of in vitro diagnostic medical devices
• Reagents: Laboratory reagents under CPV 33696500
• Kits: Diagnostic kits
• Calibration Plasmas: Plasmas for calibration
• Control Plasmas: Control plasmas for haemostasis
• Associated Services: Associated services for the supplied devices

Special Procurement Conditions

• Quality Criterion: Quality of the service (60%) – technical quality 35%, adaptation to hospital use 10%, tenderer's services 10%, sustainable development actions 5%
• Price Criterion: Price (40%)
• Framework Agreement: Framework agreement, without reopening of competition
• No Subcontracting: No subcontracting declared by winners
• Lots: Multiple lots grouped into five result lots

About the Contracting Authority

AGEPS - APHP is a body governed by public law operating in health in France.

• Legal type: Body governed by public law
• Activity: Health
• Registration number: 26750045200672
• Location: Paris (FR101), France
• Postcode: 75005
• Email: eps-logistique-equipements-medicaux2@aphp.fr
• Telephone: +33 146691334
• Buyer profile: https://www.marches-publics.gouv.fr/

About the Winning Supplier

Cryopep is a micro, small, or medium enterprise based in Montpellier, France.

• Size: Micro, small, or medium
• Registration number: 50531854300020
• Location: Montpellier, Hérault (FRJ13), France
• Postcode: 34080
• Subcontracting: No

DIAGNOSTICA STAGO is a micro, small, or medium enterprise based in Asnières sur seine, France.

• Size: Micro, small, or medium
• Registration number: 30515140900136
• Location: Asnières sur seine, Hauts-de-Seine (FR105), France
• Postcode: 92665
• Subcontracting: No

SIEMENS HEALTHCARE is a micro, small, or medium enterprise based in Courbevoie, France.

• Size: Micro, small, or medium
• Registration number: 81079480000179
• Location: Courbevoie, Hauts-de-Seine (FR105), France
• Postcode: 92412
• Subcontracting: No

SYSMEX FRANCE is a micro, small, or medium enterprise based in Villepinte, France.

• Size: Micro, small, or medium
• Registration number: 42996300200010
• Location: Villepinte, Val-d'Oise (FR108), France
• Postcode: 95944
• Subcontracting: No

WERFEN is a micro, small, or medium enterprise based in Le pré saint Gervais, France.

• Size: Micro, small, or medium
• Registration number: 56201026400116
• Location: Le pré saint Gervais, Seine-Saint-Denis (FR106), France
• Postcode: 93310
• Subcontracting: No

Evaluation Criteria

The lots use the following evaluation criteria:

• Quality (60%): Quality of the service – technical quality 35%, adaptation to hospital use 10%, tenderer's services 10%, sustainable development actions 5%
• Price (40%): Price

Procurement Analysis

• Procedure: Open procedure under the standard regime, governed by EU Directive 2014/24/EU
• Competition: 3 tenders received electronically per lot
• Subcontracting: No subcontracting declared
• No EU funding: The procurement was not financed with EU funds
• Framework agreement: Framework agreement, without reopening of competition
• No dynamic purchasing system used
• Review body: Tribunal Administratif de PARIS

Additional Procurement Facts

• The contract is covered by the WTO's Government Procurement Agreement (GPA)
• No EU funds were used for this procurement
• The total maximum value is €38,995,033.00
• The procurement is divided into five result lots
• Quality (60%) and Price (40%) are the evaluation criteria
• Three tenders were received electronically per lot
• The winners are micro, small, or medium enterprises
• No subcontracting was declared
• The estimated duration is 48 months
• The contracts were concluded on 25/09/2026

Market & Industry Perspective

The French public sector laboratory reagents market features a mix of small and medium-sized enterprises. In vitro diagnostic medical device supply is essential for maintaining hospital diagnostic operations.

Key trends in this market include:

• Balanced evaluation: 60% quality, 40% price
• SME participation: Winners are micro, small, or medium enterprises
• Comprehensive scope: Reagents, kits, calibration and control plasmas, and associated services
• Medium-term projects: 48-month duration
• Specialised supplies: Haemostasis reagents and diagnostic devices
• No subcontracting: No subcontracting declared by winners

Economic Significance

At €38,995,033.00, this contract represents a significant investment in the supply of in vitro diagnostic medical devices for the Assistance Publique - Hôpitaux de Paris. The contract will:

• Support Hospital Diagnostics: Supply reagents, kits, calibration and control plasmas for haemostasis testing
• Support SMEs: Cryopep, Diagnostica Stago, Siemens Healthcare, Sysmex France, and Werfen are micro, small, or medium enterprises
• Provide Medium-Term Delivery: 48-month duration
• Ensure Diagnostic Capability: Improve laboratory diagnostic infrastructure for hospitals
• Enable Operational Efficiency: Comprehensive supply of diagnostic devices and associated services
• Support Regional Development: Contribute to the healthcare market in the Paris region

Future Procurement Opportunities

With these contracts now in place, future opportunities include:

• Re-tender: Expected after the completion of the framework agreements
• Related Works: Additional laboratory reagent and diagnostic device procurements
• Subcontracting: Potential opportunities with the winning suppliers
• Other Hospital Projects: Similar diagnostic supply procurement opportunities
• Other Public Sector Health Procurements: Similar laboratory reagent and IVD opportunities

Opportunities for Suppliers

While these contracts are awarded, opportunities remain for laboratory reagent suppliers:

• Re-tender: Prepare for future procurement cycles
• Subcontracting: Potential opportunities with the winning suppliers
• Related Works: Other laboratory reagent and diagnostic device procurements
• Other French Public Sector Health Authorities: Similar diagnostic supply procurements
• Other Hospital Groups: Monitor further laboratory reagent opportunities

What Businesses Should Watch

• AGEPS - APHP's future procurement notices
• Other French public sector health tenders
• Laboratory reagents market trends
• Changes to French procurement regulations
• In vitro diagnostic medical device developments
• Further laboratory reagent procurement opportunities in the healthcare sector

FranceTenders.com Procurement Intelligence

This laboratory reagents framework agreement procurement is a notable example of French public sector health procurement. Several features stand out:

• Scale: €38,995,033.00 total maximum value
• Balanced evaluation: 60% quality, 40% price
• SME winners: Cryopep, Diagnostica Stago, Siemens Healthcare, Sysmex France, Werfen
• Five result lots: LOT-0001 to LOT-0005
• Competition: 3 tenders received electronically per lot
• Medium-term project: 48-month duration
• Comprehensive scope: Reagents, kits, calibration and control plasmas, and associated services
• Specialised supplies: Haemostasis diagnostic devices

For suppliers, this procurement highlights the importance of:

• Quality: 60% quality-based evaluation with sub-criteria
• Competitive pricing: 40% price-based evaluation
• Laboratory reagent expertise: Ability to deliver in vitro diagnostic medical devices
• Hospital adaptation capability: Ability to adapt to hospital use
• Sustainable development: Actions in terms of sustainable development
• Public sector experience: Understanding of French hospital requirements

Supplier Takeaways

• Demonstrate quality – 60% of evaluation is quality-based
• Offer competitive pricing – 40% of evaluation is price-based
• Showcase laboratory reagent expertise
• Demonstrate hospital adaptation capability
• Show sustainable development actions
• Develop public sector experience with French hospital authorities
• Monitor AGEPS - APHP and French public sector health procurement opportunities
• Prepare for subcontracting and future procurement opportunities

Key Takeaways

• AGEPS - APHP awarded framework agreements worth €38,995,033.00 for laboratory reagents to Cryopep, Diagnostica Stago, Siemens Healthcare, Sysmex France, and Werfen
• Five result lots: LOT-0001 to LOT-0005
• Duration: 48 months
• Evaluation: Quality (60%) and Price (40%)
• 3 tenders received electronically per lot
• Winners are micro, small, or medium enterprises
• No subcontracting declared
• No EU funding
• Covered by GPA: Yes
• Framework agreement, without reopening of competition
• Comprehensive scope: reagents, kits, calibration and control plasmas for haemostasis, and associated services
• Contracts concluded on 25/09/2026

Conclusion

These laboratory reagents framework agreements ensure the supply of in vitro diagnostic medical devices, reagents, kits, calibration and control plasmas for haemostasis, and associated services for all establishments of the Assistance Publique - Hôpitaux de Paris, supporting hospital diagnostic operations. By awarding the contracts to Cryopep, Diagnostica Stago, Siemens Healthcare, Sysmex France, and Werfen, AGEPS - APHP secures reliable SME suppliers with the capability to deliver comprehensive laboratory reagent supplies.

The 60% quality and 40% price evaluation reflects the balanced nature of healthcare procurement, where both quality and cost are important differentiators among qualified suppliers. The 48-month duration, the comprehensive scope and the specialised supplies reflect the specific operational and strategic context of the laboratory reagent procurement.

For suppliers, this procurement highlights the importance of quality, competitive pricing, laboratory reagent expertise, hospital adaptation capability, sustainable development actions, and public sector experience in winning French public sector health contracts.

Frequently Asked Questions

Q: What is AGEPS - APHP?

Ans: A body governed by public law operating in health in France, responsible for procurement for the Assistance Publique - Hôpitaux de Paris.

Q: What is the value of the contract?

Ans: Total maximum value €38,995,033.00.

Q: Who are the winners?

Ans: Cryopep, Diagnostica Stago, Siemens Healthcare, Sysmex France, and Werfen, all micro, small, or medium enterprises based in France.

Q: What supplies are covered?

Ans: In vitro diagnostic medical devices: reagents, kits, calibration and control plasmas for haemostasis, and associated services.

Q: What were the evaluation criteria?

Ans: Quality (60%) and Price (40%).

Q: How long is the contract?

Ans: 48 months.

Q: How many tenders were received?

Ans: Three tenders received electronically per lot.

Q: Is this contract funded by the EU?

Ans: No, the procurement is not financed with EU funds.

Q: What is the review body?

Ans: Tribunal Administratif de PARIS.

Q: What is the lot structure?

Ans: Five result lots – LOT-0001 (CRYOPEP Lots 13 et 35), LOT-0002 (DIAGNOSTICA STAGO lot 1), LOT-0003 (Siemens healthcare lot 3), LOT-0004 (Symex france Lots n° 4), LOT-0005 (Werfen Lots n° 2, 9, 10 et 26).

Q: Is subcontracting allowed?

Ans: No subcontracting was declared by the winners.

Q: What is the main CPV classification?

Ans: 33696500 Laboratory reagents.

Source: EU Official Journal, Contract Award Notice 678067-2026, OJ S 191/2026, published 02 October 2026.

```